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A B S T R A C T
Artemether (ARM) is a poorly water soluble and poorly permeable drug effective against acute
and severe falciparum malaria, hence there is a strong need to improve its solubility. The
objective of the study was to enhance the solubility and dissolution rate of ARM by prepa-
ration of solid dispersions using spray-drying technique. Solid dispersions of ARM were
prepared with Soluplus, Kollidon VA 64, HPMC and Eudragit EPO at weight ratios of 1:1, 1:2,
1:3 using spray drying technology, and characterized by Fourier transform infrared spec-
troscopy, differential scanning calorimetry (DSC), and X-ray powder diffraction (XRD) to identify
the physicochemical interaction between drug and carrier, as well as effect on dissolution.
The prepared solid dispersion of ARM with polymers showed reduced crystallinity as com-
pared to neat ARM, which was confirmed by DSC and XRD. Drug/polymer interactions were
studied in-silico by docking and molecular dynamics which indicated formation of van der
Waals type of interactions of ARM with the polymers. Based on solubility studies, the optimum
drug/Soluplus ratio was found to be 1:3. The dissolution studies of formulation SD3 showed
highest drug release up to 82% compared to neat ARM giving only 20% at 60 minutes. The
spray-dried products were free of crystalline ARM; possessed higher dissolution rates, and
were stable over a period according to ICH guidelines. These findings suggest that an amor-
phous solid dispersion of ARM could be a viable option for enhancing the dissolution rate
of ARM.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Shenyang Phar-
maceutical University. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Artemisinin is an important class of antimalarial drugs, struc-
turally characterized by incidence of a sesquiterpene lactone
with a peroxide bridge and is the active constituent of the
Chinese medicinal herb Artemisia annua [1–3]. Different types
of active metabolites of artemisinin have been synthesized, viz.
artemether, artesunate, and arteether are currently in use or
under clinical trials [4].
β-Artemether [5] is one of the artemisinin derivatives which
has been proven to be effective against acute uncomplicated
and severe falciparum malaria [6]. ARM is active against Plas-
modium vivax as well as chloroquine-sensitive and chloroquine-
resistant strains of Plasmodium falciparum. ARM is also indicated
in the treatment of cerebral malaria. ARM, having the chemi-
cal structure as shown in Fig. 1, shows rapid onset of
schizontocidal action and is metabolized in the liver to a
demethylated derivative, dihydroartemisinin. However, the
therapeutic potential of ARM is markedly delayed due to its
low oral bioavailability. The low bioavailability of ARM results
from its poor aqueous solubility [5], resulting in poor absorp-
tion upon oral administration. This is due to a large fraction
of the drug that remained undissolved to reach absorption site.
Under such conditions, the bioavailability can be increased by
using a water-soluble formulation [6].
IUPAC name: [7]-[8a-beta,9-alpha,12-beta,12aR]-decahydro-
10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[9]-1,2-
benzodioxepin.
Formulation scientists are working on different approaches
to enhance the dissolution rate of poorly soluble drugs in-
cludes, solid dispersions prepared by spray-drying [7,8], freeze-
drying [9], mechanical milling [10], hot melt extrusion [11,12],
supercritical fluid extraction [13,14], co-crystal formation [15,16],
inclusion complexation using cyclodextrins [17], microencap-
sulation [18], and particle size reduction [19,20]. However, most
of these approaches face demerits of scale up issues or eco-
nomic challenge.
Literature reports that solid dispersion [21] using water-
soluble polymers showed good improvement in dissolution rate
and bioavailability. Researchers have established various ap-
proaches for dissolution rate enhancement of ARM with PEG
6000 and PVP by solvent evaporation and lyophilization method
[22], ARM with PEG 4000 and PVP K25 by freeze-drying and melt
extrusion method [23], and ARM inclusion complexes with
hydroxypropyl β-cyclodextrin [2] microencapsulation [18]. In
addition, spray drying technology has also explored for solubility
enhancement ARM using polyvinylpyrrolidone as a carrier [21],
also by making microparticles of ARM [24] and using polyeth-
ylene glycol as hydrophilic polymer [25]. The ARM–Soluplus SD
system has been developed using hot melt extrusion technol-
ogy for improving the dissolution rate of ARM [5].
Spray drying is known to produce predominately-amorphous
material due to the instantaneous transition between liquid
and solid phases. In spray drying, the drug–polymer solution
is atomized and dispersed into hot gas, which causes the
solvent to evaporate and leads to the generation of spherical
solid particles [26]. Spray drying is the most universally used
industrial process as the product from spray drying process
meets the highest quality standards with reference to the par-
ticle size, shape, homogeneity, and uniform distribution of
products. Different types of particles can be produced by this
technology [27,28]. The wide variety of processing param-
eters [25] makes it a powerful technique to tune the physical
state [29] and the particle morphology of pharmaceutical
systems [30].
The present study aims to elucidate the potential of en-
hancing the solubility and dissolution rate of ARM using
hydrophilic polymers like Soluplus, Kollidon VA 64, HPMC and
Eudragit EPO by spray-drying technology. Kollidon VA 64 is a
water-soluble vinylpyrrolidone–vinyl acetate copolymer. Low
viscosity HPMC is an odorless and tasteless, white or creamy-
white fibrous or granular powder. It is partly O-methylated and
O-cellulose [31]. Soluplus is a polyvinyl caprolactam–polyvinyl
acetate–polyethylene glycol graft copolymer, a new polymer with
amphiphilic properties [5]. Eudragit EPO is a cationic copoly-
mer based on dimethylaminoethyl methacrylate, butyl
methacrylate, and methyl methacrylate. It is a white powder
with a characteristic amine-like odor.
The chemical interaction of ARM with the polymers trig-
gering enhancement in solubility of ARM was simulated in silico
by means of docking and molecular dynamics [18].The docking
analysis mimics the drug binding to proteins to understand
the interactions occurring at the molecular level. This ap-
proach has found relevant applications in material science,
particularly in the area of drug–polymer interactions [32]. Some
authors have exploited in silico studies to predict and ratio-
nalize the design of drug delivery systems as well [33–35]. In
the present study, we attempted to study the interactions
between ARM and the respective polymers viz. Soluplus,
Kollidon VA 64, HPMC and Eudragit EPO by combining docking
and molecular dynamics study [18]. The analysis of the mo-
lecular phenomena involved in the recognition capability of
polymeric complex represents clearly an intricate but fasci-
nating research topic, which has been implicated from the
results.
In the present study, we attempted to simulate the inter-
actions between ARM and the respective hydrophilic polymers
combining several computational techniques. In particular, the
polymers were simulated as functional oligomers simplify-
ing the whole composition and structures and therefore
maintaining the recognition properties.
ARM solid dispersions were prepared by spray drying tech-
nology from various ratios of Soluplus, Kollidon VA 64, HPMC
and Eudragit EPO as hydrophilic polymeric carriers. Further-
more, the study undertakes to investigate solid-state
characterization using differential scanning calorimetry (DSC),Fig. 1 – Chemical structure of ARM.
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powder X-ray diffractometry (XRD) and attenuated total
reflectance–Fourier transform infrared (ATR-FTIR) spectros-
copy, and morphological characterization using scanning
electron microscopy (SEM) and studied their dissolution prop-
erties along with in silico studies to predict possible mechanism
for improved dissolution rate with the respective polymers.
2. Materials and methods
2.1. Materials
ARM was obtained as a generous gift from Mangalam Drugs
and Organics Ltd. Mumbai, India. The polymers, viz. Soluplus
and Kollidon VA 64, were gifted from BASF AG (Germany).
Eudragit EPO and HPMC were obtained as gift samples from
Evonik industries (Germany) and Dow Chemicals (India) re-
spectively. All other chemicals and solvents used were of
analytical grade and were procured from Merck India Ltd. All
the materials were used as received.
2.2. Method
2.2.1. Preparation of ARM solid dispersions by spray drying
technique
ARM SDs with the different hydrophilic polymers were ob-
tained by spray drying (water : acetone, 20:80) solutions of ARM
with other hydrophilic polymers. The spray drying was carried
out using the instrument Spray dryer SD-1100 (JISL, Mumbai,
India). ARM (5 gm/batch) was dissolved in 10 mL of acetone.
The other hydrophilic polymers were dispersed in 160 mL of
distilled water in different ratios as shown in Table 1.
The organic phase was then slowly added to aqueous phase
on magnetic stirrer with continuous stirring for a period of
30 min. The solid concentration was varied depending upon
the different batch ratios. The SDs were prepared using a spray
dryer with the following conditions: inlet temperature of
70–72 °C, feed rate of 3 ml/min, outlet temperature of 42–44 °C,
and aspirator set to at 40 m3/h; the spray dryer had a nozzle
diameter of 1 mm.The spray-dried particles were collected into
parafilm-sealed scintillation vials, and the closed vials were
stored at room temperature prior to analysis. A physical mixture
of ARM with Soluplus, Kollidon VA 64, HPMC and Eudragit EPO
was also prepared by carefully mixing the two substances in
a glass vial [36].
2.3. Apparent solubility study
Solubility study was carried out for neat ARM and ARM SDs
in 20 ml of distilled water containing 1% SLS and phosphate
buffer of pH 7.2 containing 1% SLS to check out the maximum
solubility of ARM and ARM SDs in respective dissolution media
after 72 hrs. An excess amount of ARM and ARM SDs made up
of Soluplus, Kollidon VA 64, HPMC and Eudragit EPO in the ratios
of 1:1, 1:2, and 1:3 was added to 10 ml of freshly prepared dis-
tilled water containing 1% SLS and phosphate buffer of pH 7.2
containing 1% SLS in clean test tubes and sealed. The samples
were then sonicated for 15 min at room temperature. There-
after, the test tubes were shaken for 72 hrs at 37 ± 0.5 °C at a
speed of 75 rpm on an orbital shaking thermostable incuba-
tor (Boekel Scientific, Germany). The samples were centrifuged
at 10,000 rpm for 10 min and filtered through a 0.45 μm Millipore
membrane filter. The first 1 mL of the filtrate was discarded.
Samples were then suitably diluted with the respective dis-
solution medium and analyzed at 211 nm on UV-
spectrophotometer (UV-1601 PC, Shimadzu, Japan). All solubility
measurements were performed in triplicates.
2.4. Structural analysis by FTIR
FTIR analysis was done to investigate the molecular struc-
tures of ARM and Soluplus, Kollidon VA 64, HPMC and Eudragit
EPO and their SD systems.The samples were analyzed for their
functional groups using Shimadzu MIRACLE IR Affinity-1 FTIR
spectrophotometer.The samples were premixed with KBr using
mortar and pestle, and KBr disks were prepared by means of
a hydraulic press. The scanning range was 4000–400 cm−1 reso-
lution of 4 cm−1.
2.5. Thermal analysis (DSC)
DSC analysis was performed to check the physical state of SDs
with respect to neat ARM and Soluplus, Kollidon VA 64, HPMC
and Eudragit EPO polymers, respectively, using Pyris-6 DSC
Perkin Elmer (USA). Approximately 3–4 mg of sample was placed
Table 1 – Different solid dispersion batches containing ARM and polymers in ratios.
SD batch ARM : polymer ratios ARM Soluplus Kollidon VA 64 HPMC Eudragit EPO
SD1 1:1 1 1
SD2 1:2 1 2
SD3 1:3 1 3
SD4 1:1 1 1
SD5 1:2 1 2
SD6 1:3 1 3
SD7 1:1 1 1
SD8 1:2 1 2
SD9 1:3 1 3
SD10 1:1 1 1
SD11 1:2 1 2
SD12 1:3 1 3
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in aluminum pan and crimped using a press. An empty alu-
minum pan was used as a blank. Samples were heated at the
rate of 10 °C/minute from 30 °C to 300 °C under 17 ml/min of
nitrogen flow to obtain the endothermic peaks.
2.6. Crystallinity studies (PXRD)
X-ray diffraction studies were done for physical characteriza-
tion of SDs. X-ray diffraction patterns were obtained by
ADVANCE D8 system with CuKα radiation (Bruker, USA). The
recording spectral range was set at 10°–50° (2θ) using the Cu-
target X-ray tube and Xe-filled detector. The voltage 40 kV with
current 20 mA was set.The samples were placed in a zero back-
ground sample holder and incorporated on a spinner stage.
Soller slits (0.04 rad) were used in the incident and diffracted
beam path.
2.7. Confirmation of surface morphology by SEM
The particulate morphologies of the ARM powder and ARM SD
were examined using a scanning electron microscope (XL 30
Model JEOL 6800 SEM Tokyo, Japan). The powder samples ARM
and ARM SD were spread on a carbon fiber tape, and sample
coated by platinum–palladium during 100 s under argon gas.
The samples were observed on 15.0 kV.
2.8. Encapsulation efficiency study
An amount of the SD sample containing about 40 mg of ARM
was weighed and dissolved in sufficient methanol to produce
100 ml.The resulting solution was filtered using a sintered glass
crucible, discarding the first 10 ml. 2 ml of the resulting solu-
tions was pipetted into a quick-fit test tube and 2 ml of
concentrated HCl was added. The test tubes were stoppered
and allowed to stand in a water bath at room temperature for
25 minutes. The resulting solutions were diluted with suffi-
cient methanol to 50 ml.The absorbance reading at a maximum
of 211 nm was taken against a blank solution made up of 2 ml
of HCl made up to 50 ml with methanol. The contents of ARM
were calculated from the calibration curve. Encapsulation ef-
ficiency was defined by the actual amounts of ARM in the
prepared SDs according to Eq. (1) [35].
Encapsulation fficiency Actual rug oading
Theoretical dr
e d l=
ug loading × 100%
(1)
2.9. In vitro dissolution study
A dissolution study of ARM and SDs was performed using USP
basket method by dissolution apparatus (Electrolab Pvt. Ltd.
India) at 37 ± 0.2 °C. Samples equivalent to 40 mg of ARM SDs
were filled in hard gelatin capsules and were added to disso-
lution media containing 1000 ml phosphate buffer of pH 7.2
with 1% SLS (sodium lauryl sulfate) at a temperature of
37 ± 0.2 °C. The solutions were stirred with a rotating basket
at 100 rpm. Samples (5 ml) were withdrawn from each vessel
at predetermined time intervals (10, 20, 30, 40, 50, 60, and
120 min), filtered over a cellulose acetate filter of 0.45 μm. At
each time point, the same volume of fresh medium maintained
at the same temperature was added to dissolution media to
maintain the sink conditions.The concentration of ARM in each
sampled aliquot was determined using an UV-visible spectro-
photometer at 211 nm and a standard calibration curve that
was linear over the UV absorbance range.
2.10. In silico molecular modeling studies
All modeling studies were carried out using Schrödinger’s
Maestro software [37] installed on Fujitsu Celsius worksta-
tions. Structures of ARM, Soluplus, Kollidon VA 64, HPMC and
Eudragit EPO were built using 2D sketcher utility based on lit-
erature reports and further prepared using Ligprep [38]. Docking
analysis was carried out using flexible docking option in Glide
module [39]. The, ARM–HPMC, ARM–Eudragit EPO and ARM–
Soluplus complexes were generated by docking. The ARM–
Kollidon VA 64 complex was generated and subjected to
Macromodel minimization [40].
The lowest energy complexes obtained from docking were
subjected to system builder panel and further to the default
protocol and finally to 10 ns MD simulations in vacuum using
Desmond [41].The lowest energy complexes obtained from these
MD simulation were used to analyze the interaction of ARM
with the different polymers. The simulations were performed
using NVT ensemble with OPLS_2005 force field [42].
The Nose–Hoover thermostat [43] was used to maintain tem-
perature at 300 K. periodic boundary conditions were applied
throughout and equations of motion were integrated using the
multistep RESPA integrator [44] with inner time step of 2.0 fs
for bounded interactions and non-bonded interactions within
the short range cutoff. An outer time step of 6.0 fs was used
for non-bonded interactions beyond the cutoff. The outputs of
the simulation were collected every 10 ps over the trajectory
during the production runs and analyzed using the different
tools in Desmond.
3. Results and discussion
3.1. Drug solubility study
The influence of different hydrophilic polymers on apparent
solubility of the ARM was calculated. As presented in Table 2,
it can be seen that the solubility study of SDs made by spray
drying showed an increase in the drug solubility with an in-
crease in the ratio of hydrophilic polymers. The solubility of
pure ARM in distilled water containing 1% SLS was found to
be 0.0180 μg/mL, indicating its poor solubility. Table 2 shows
the solubility data of the spray dried SDs of ARM with differ-
ent polymers marked a difference compared to neat ARM.
A linear relationship was observed with respect to in-
crease in solubility of ARM to increasing ratio of Soluplus,
Kollidon VA 64, HPMC and Eudragit EPO. The spray drying
process causes the decrease in particle size of SDs. According
to the Noyes–Whitney equation [1,45], the dissolution rate and
saturation solubility of drugs can be increased by reducing the
particle size, causing an increase in particle surface area [46].
This implies the solubilizing properties of hydrophilic polymers
388 a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 3 8 5 – 3 9 5
for ARM using spray-drying technology. 1:1, 1:2 and 1:3 ratios
of ARM with Soluplus, Kollidon VA 64, HPMC, and Eudragit EPO
enhanced the solubility of ARM in water up to an extent 80.22,
73.29, 67.39 and 72.24 μg/ml, respectively.
The solubility of pure ARM and SDs was higher in medium
2 as compared to medium 1. The hydrophilic polymers like
Soluplus by hot melt extrusion technology [5] and using poly-
vinylpyrrolidone [46] have been reported to increase the
solubility of ARM. The increase in solubility in both dissolu-
tion media could probably be elucidated by hydrophilic
environment created by the carrier around the drug resulting
in a decrease in particle size of SDs and increased wettability
of ARM. The increase in solubility could also be because of a
decrease in the interfacial tension between the drug and the
dissolution medium.
3.2. Fourier transform infrared spectroscopy (FTIR)
The FTIR spectra of neat ARM, Soluplus, SD3 and Kollidon VA
64 and SD6 are shown in Fig. 2a, and ARM, HPMC, SD9, Eudragit
EPO and SD12 are shown in Fig. 2b. The FTIR spectra of ARM
shows different peaks in fingerprint region like, peak at
1250 cm−1 for C—O, peak at 1450 cm−1 is found for C—C bending,
a peak at 1138 cm−1 can be assigned to C—H stretching vibra-
tion in C—O—C component, respectively representing 1,2,4-
trioxane ring. The functional group region peak at 3129 cm−1
is observed for C—H stretching in -CH3.
Table 2 – Solubility of ARM and SDs.
Drug loaded SDs Medium 1 (μg/ml) Medium 2 (μg/ml)
ARM 0.018 ± 0.9 38.71 ± 1.9
SD1 37.12 ± 1.1 176.51 ± 1.7
SD2 54.17 ± 1.2 210.44 ± 1.5
SD3 80.22 ± 1.4 291.53 ± 1.4
SD4 25.54 ± 1.3 148.91 ± 1.6
SD5 51.56 ± 1.0 207.57 ± 1.4
SD6 73.29 ± 1.4 253.42 ± 1.6
SD7 34.44 ± 1.2 137.38 ± 1.4
SD8 48.31 ± 1.4 214.42 ± 1.7
SD9 67.39 ± 1.1 267.44 ± 1.8
SD10 36.44 ± 1.3 147.50 ± 1.7
SD11 47.21 ± 1.2 231.92 ± 1.9
SD12 72.24 ± 1.0 277.07 ± 1.7
Medium 1: distilled water containing 1% SLS; Medium 2: phos-
phate buffer pH 7.2 containing 1% SLS.
Fig. 2 – FTIR spectra’s of ARM (a), Soluplus (b), SD 3 (c), Kollidon VA64 (d), SD 6 (e), HPMC (f), SD 9 (g), Eudragit EPO (h) and SD
12 (i).
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In case of Soluplus and Kollidon VA 64, HPMC and Eugragit
EPO all these hydrophilic polymers showed that a peak at 1450–
1480 cm−1 is found for C—C binding. It also showed a broad band
at 3000–3500 cm−1, which was attributed to the presence of more
numbers of -OH stretching groups.
Soluplus, Kollidon VA64 and HPMC showed a very broad band
at 3430 cm−1 which was attributed to the presence of water as
both of these polymers are hygroscopic in nature and absorbs
moisture from the environment. All the polymers have a hy-
drophilic surface with lots of hydrophilic groups, resulting into
diffusion of dissolution medium and accelerated release of ARM
[47].
The shifting of O—H and C—H stretching vibrations in FTIR
spectra revealed red and blue shifting of the carbonyl group
in the fingerprint region, indicating an interaction between ARM
and the respective hydrophilic polymers. The extent of inter-
action varied depending on the nature and molecular weight
of the carriers and on the drug–polymer ratio. An increase in
the ratio of polymer to the ARM indicated that high polymer
binding to the drug improves the pharmaceutical efficiency of
SDs.
3.3. Differential scanning calorimetry (DSC) studies
The DSC thermograms of neat ARM, Soluplus, Kollidon VA 64,
HPMC and Eudragit EPO and spray dried SDs are shown in Fig. 3.
Pure ARM started melting at 84.86 °C with a sharp endother-
mic peak at 86.64 °C and an exothermic peak at 172 °C with
enthalpy change of 56.68 J/g, whereas all pure hydrophilic poly-
mers did not show a melting endotherm because of its
amorphous nature. SDs of ARM showed a slight decrease in
ΔH and peak height, in accordance with XRD patterns.The SD3,
SD9 and SD12 showed a very small endothermic peak at a lower
temperature compared to the neat ARM, indicating some crys-
tallinity; the results are in resemblance with the XRD data, as
SD6 has not shown any peak in DSC thermogram as well as
XRD diffractogram.
The heat of fusion of the pure ARM was higher than that
of spray dried SDs. The heat of fusion of SDs depended on the
ratio of polymer to pure ARM and spray drying conditions such
as inlet temperature and feed rate. The heat of fusion de-
creased with the increase in polymer ratio. The heat of fusion
is proportional to the amount of crystallinity of the samples.
These results suggest that the crystalline nature of ARM was
diminished when they were processed by spray drying
technique-forming SDs. Therefore, it seems that amorphous
systems can be formed using spray drying technology.
3.4. X-ray diffraction studies
The representative X-ray diffarctograms of ARM and opti-
mized SDs are shown in Fig. 4, which illustrates the changes
in drug crystal structure. X-ray diffraction studies were per-
formed to elucidate the physical state of the pure ARM in the
SDs. The X-ray patterns of ARM presented numerous distinct
peaks at 2θ values of 7.29°, 10.04°, 18.04° 19.68° and 22.1°, in-
dicating the crystalline nature of the drug; data resembled those
in previous literature [21,25]. Soluplus, Kollidon VA 64, Eudragit
EPO and HPMC polymers are amorphous in nature so the XRD
analysis has not been carried out. The spray dried ARM par-
ticles showed a similar diffraction pattern as of pure ARM, but
with lower peak intensity, inferring that the crystallinity of
spray-dried SDs of SD3 and SD6 decreased during the spray
drying process. The high peak intensity signal of ARM drug at
2θ value of 10.04° was found to be absent in the XRD of SDs
of ARM indicating stronger interactions with all hydrophilic
Fig. 3 – DSC thermograms of ARM (a), Soluplus (b), Kollidon VA 64 (c), SD 3 (d), SD 6 (e), HPMC (f), Eudragit EPO (g), SD 9 (h) SD
12 (i).
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polymers. The X-ray patterns of the SDs were changed due to
the polymer to drug ratios and also the spray drying condi-
tions like feed flow rate and temperature. From the X-ray
patterns of SD9 and SD12, we can conclude that the crystal-
line nature of ARM was still maintained due to excess drug that
remained in the spray drying process, so some peaks with
reduced intensity were still observed, indicating partial crys-
tallinity. The diffractograms of SD3 and SD6 were found
completely amorphous in nature absence of any peak.The new
peaks observed in case of SD9 and SD 12 suggested some physi-
cal interaction between the drug and the polymer, which lead
to changes in the crystal structure. The results are in resem-
blance with the FTIR data as well as in-silico studies. From the
XRD observations of SD9 and SD12, we can conclude that ARM
was still available in its crystalline nature, but the relative drop
in the diffraction intensity of ARM in SDs suggests that some
crystals remained in SDs.
3.5. Scanning electron microscopy (SEM) studies
SEM micrographs of pure ARM, Soluplus and ARM SDs are
shown in Fig. 5. From the SEM micrograph, it was evident that
spray drying of ARM resulted in a significant particle size re-
duction of ARM. SEM micrographs of pure ARM in Fig. 5a
revealed large crystalline blocks, the particles were lacking
uniformity in size and comparatively larger than the spray dried
SDs, whereas ARM SD3, SD6, SD9 and SD12 were found to be
without sharp edges and uniform particles. Extensive depo-
sition of the ARM was observed on Soluplus in case of SD3.
This may be due to the large surface area imparted by the hy-
drophilic nature of the polymers. The other ARM SD6, SD9 and
SD12, appeared to be agglomerated and offered a smooth
surface owing to the presence of hydrophilic polymers. The
spray-dried particles showed more homogeneity, which was
more noticeable at the higher inlet temperature of the spray
drying process. The higher feed concentration and outlet tem-
perature did not influence the morphology of ARM during the
spray drying process.
3.6. Encapsulation efficiency of prepared solid dispersions
The encapsulation efficiency of the prepared SDs in various
ratios of polymers is shown in Table 3. Solid dispersions with
the low encapsulation efficiency were due to the non-
encapsulated drug in the polymer, whereas solid dispersions
with the high encapsulation efficiency were greatly encapsu-
lated in the polymer. The encapsulation efficiency was
enhanced by increasing the ratios of polymers. Additionally,
it is viewed that SDs with the relatively low encapsulation ef-
ficiency were because of the well non-bonding ARM in polymers.
Fig. 4 – PXRD patterns of pure ARM (a), SD 3 (b), SD 6 (c), SD 9 (d), SD 12 (e).
Table 3 – Percentage encapsulation of SDs.
Batch SD1 SD2 SD3 SD4 SD5 SD6 SD7 SD8 SD9 SD10 SD11 SD12
Encapsulation efficiency (%) 94.53 92.36 97.62 93.14 98.13 97.64 95.63 98.89 93.21 95.63 97.32 96.33
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3.7. Dissolution studies of ARM SDs
For the assessment of dissolution rate improvement, dissolu-
tion studies were conducted. The in vitro dissolution profile of
pure ARM and SDs of ARM are shown in Fig. 6, respectively. It
is seen that more than 82% of ARM was dissolved from the
SD3 of ARM : Soluplus compared to pure ARM showing only
20% drug release after 60 min. The dissolution profile of the
Fig. 5 – SEM images of pure ARM (a), Soluplus (b), SD 3 (c), SD 6 (d), SD 9 (e), and SD 12 (f).
Fig. 6 – In vitro release of formulation batches from SD1 to SD12 in phosphate buffer pH 7.2 containing 1% SLS (mean ± SD).
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SD formulation of ARM with Soluplus, Kollidon VA 64, HPMC
and Eudragit EPO showed drug release (SD3 = 81.99%,
SD6 = 40.58%, SD9 = 64.71% and SD12 = 47.32%, respectively, at
the end of t60 minutes) compared to 20.77% of pure ARM. The
drug dissolution increased with increasing the amount of the
drug carrier. However, by observing the relative standard de-
viation values (represented by error bars in Fig. 6), it was
concluded that only the spray-dried SDs showed a very rapid
and uniform dissolution, which is a significant characteristic
of the dissolution profile [29]. Therefore, the results obtained
in this study suggested that the complexation of ARM with poly-
mers could be used as a formulation strategy for solubility and
dissolution rate enhancement.
The increase in the dissolution rate in the case of the SD
formulation is attributed to the amorphous state of the ARM
that offers a lower thermodynamic barrier to dissolution and
the formation dispersion where the drug is dispersed inside
the hydrophilic polymers. An amorphous formulation system
will dissolve at a faster rate because of its higher internal energy
and superior molecular motion [48]. Our spray dried ARM for-
mulations with the increased dissolution rate could be
deciphered into an enhanced bioavailability formulation upon
oral administration.
3.8. In silico studies of ARM with hydrophilic polymers
Molecular modeling studies have shown that the drug forms
complexes of ARM with the polymers. ARM was seen to form
strong van der Waals interaction with the polymers. In case
of Soluplus, good hydrophobic contacts were seen between the
CH2 group of oxirane ring of the ARM and CH2 group of polymer
and CH3 of the same ring with the CH2 group of polymer. O
(oxygen) of the oxirane ring shows hydrogen bond (distance
1.92 Å) with the OH group of Soluplus as shown in Fig. 7.
In silico studies on HPMC, shown in Fig. 8, infer that it formed
good hydrophobic contacts such as interactions of the CH3 group
attached to the oxirane ring of ARM with the CH2 group of HPMC
and phenyl ring of ARM interacting with the CH2 groups of the
polymer.
Eudragit EPO showed vdW interactions between the phenyl
ring and CH3 group of the ARM as shown in Fig. 9.
Modeling studies on Kollidon VA64 and ARM showed for-
mation of vdW interactions between the polymer and ARM in
the lowest energy pose obtained from MD simulations as shown
in Fig. 10.
4. Conclusion
The study demonstrated that SDs of ARM formed by spray
drying technique using hydrophilic polymers like Soluplus,
Kollidon VA 64, HPMC and Eudragit EPO show a significantly
higher dissolution rate. In-silico studies indicated that ARM pri-
marily forms van der Waals interactions with the hydrophilic
polymers, in addition to hydrogen bonding as seen in case of
Soluplus. Thus, we can conclude that spray-drying technique
Fig. 7 – ARM : Soluplus SD showing formation of hydrogen
bonding along with good van derWaals interactions.
Fig. 8 – ARM : HPMC SD showing formation of good van der
Waals contacts between drug and polymer.
Fig. 9 – ARM : Eudragit EPO SD showing formation of good
van derWaals contacts between drug and polymer.
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produces an amorphous spherical-shaped ARM, which inter-
acts with the hydrophilic polymers primarily via van der Waals
type of interaction, and this in combination with the effect of
hydrophilic polymers increases the dissolution rate of the poorly
water-soluble drug ARM, which could translate into increased
bioavailability upon oral administration. This hypothesis can
be explored in further studies.
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